Sonoco (SON) Q3 2025 Earnings Call Transcript

Sonoco posted record Q3 results with net sales up 57% to $2.1 billion, adjusted EBITDA up 37% to $386 million, and adjusted EPS up 29% to $1.92, aided by the Metal Packaging EMEA acquisition, pricing, and FX. Management also signed a deal to sell ThermoSafe for up to $725 million, which should reduce net leverage to about 3.4x, but it cut full-year guidance to $7.8 billion-$7.9 billion of sales, $1.3 billion-$1.35 billion of EBITDA, and $5.65-$5.75 of EPS due to softer EMEA and Asia demand. The tone is constructive on execution and deleveraging, but cautious on near-term demand, interest expense, and Europe/Africa market weakness.

Analysis

SON’s print is less a cyclical earnings beat than a balance-sheet and portfolio-complexity trade. The acquisition/consolidation of Metal Packaging EMEA plus the ThermoSafe sale creates a cleaner earnings base, but the near-term market is still anchoring on Europe weakness and the delayed realization of synergies; that gap should keep multiple expansion capped until the February Investor Day proves the 2026 bridge. The key second-order effect is that management is explicitly choosing footprint rationalization over volume defense, which usually improves conversion margins with a lag but can suppress reported growth for 2-3 quarters.

The more important bullish setup is that SON is transitioning from a “sum-of-parts story” to a cash-recycling story. If leverage falls toward 3.4x and interest expense drops after closing, equity holders get two embedded options: buybacks or accelerated restructuring once the debt target is hit. That means the stock is likely to rerate only after the market sees not just synergy promises, but evidence that 2026 free cash flow can absorb restructuring charges while still de-levering.

The main risk is that EMEA is not merely soft, but structurally lower-quality than underwritten: seasonality, mix degradation, and customer inventory discipline can easily create another quarter or two of negative operating leverage before the footprint actions bite. If procurement synergies are front-loaded less than the street expects, and if interest savings arrive later than modeled, the “cleaner” SON could still be an earnings-fade story into early 2026. In contrast, a sharper-than-expected Q4 volume trough or stabilization in Africa/seafood would likely be enough to force a short-covering rally because expectations are already conservative.

Key Decisions for Investors

• Long SON on pullbacks over the next 2-6 weeks ahead of Investor Day; target a 10-15% rerating if management credibly quantifies the 2026 synergy bridge and debt paydown cadence.
• Use a call spread in SON (e.g., 6-9 month horizon) rather than stock if owning into February; risk/reward favors upside convexity because near-term execution noise is already well telegraphed.
• Pair trade: long SON / short a more Europe-exposed packaging peer with weaker balance-sheet optionality; SON has a clearer deleveraging path and more visible cash release from ThermoSafe.
• If SON rallies sharply on the ThermoSafe close, take partial profits unless Q4 commentary shows EMEA stabilization; the stock still needs proof that margin gains are durable without favorable mix.
• Watch for a post-close setup to add on any dip caused by restructuring charges or weak European volumes; those are likely timing issues, not thesis breakers, over a 12-month horizon.